I'll make you the following wager - that in 2017 lambda has bigger sales than the INHX drug…
I’m not particularly bullish on INX-189, so such a bet makes no sense for me. The point I was trying to make is that BMY never talks about Lambda anymore, and I consider this sufficient evidence that ZGEN shareholders were not robbed.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”